General Information of the Protein
Protein ID
PT01902
Protein Name
Serine-protein kinase ATM
Secondarily
Protein Name
Ataxia telangiectasia mutated
Gene Name
ATM
Sequence
MSLVLNDLLICCRQLEHDRATERKKEVEKFKRLIRDPETIKHLDRHSDSKQGKYLNWDAVFRFLQKYIQKETECLRIAKPNVSASTQASRQKKMQEISSLVKYFIKCANRRAPRLKCQELLNYIMDTVKDSSNGAIYGADCSNILLKDILSVRKYWCEISQQQWLELFSVYFRLYLKPSQDVHRVLVARIIHAVTKGCCSQTDGLNSKFLDFFSKAIQCARQEKSSSGLNHILAALTIFLKTLAVNFRIRVCELGDEILPTLLYIWTQHRLNDSLKEVIIELFQLQIYIHHPKGAKTQEKGAYESTKWRSILYNLYDLLVNEISHIGSRGKYSSGFRNIAVKENLIELMADICHQVFNEDTRSLEISQSYTTTQRESSDYSVPCKRKKIELGWEVIKDHLQKSQNDFDLVPWLQIATQLISKYPASLPNCELSPLLMILSQLLPQQRHGERTPYVLRCLTEVALCQDKRSNLESSQKSDLLKLWNKIWCITFRGISSEQIQAENFGLLGAIIQGSLVEVDREFWKLFTGSACRPSCPAVCCLTLALTTSIVPGTVKMGIEQNMCEVNRSFSLKESIMKWLLFYQLEGDLENSTEVPPILHSNFPHLVLEKILVSLTMKNCKAAMNFFQSVPECEHHQKDKEELSFSEVEELFLQTTFDKMDFLTIVRECGIEKHQSSIGFSVHQNLKESLDRCLLGLSEQLLNNYSSEITNSETLVRCSRLLVGVLGCYCYMGVIAEEEAYKSELFQKAKSLMQCAGESITLFKNKTNEEFRIGSLRNMMQLCTRCLSNCTKKSPNKIASGFFLRLLTSKLMNDIADICKSLASFIKKPFDRGEVESMEDDTNGNLMEVEDQSSMNLFNDYPDSSVSDANEPGESQSTIGAINPLAEEYLSKQDLLFLDMLKFLCLCVTTAQTNTVSFRAADIRRKLLMLIDSSTLEPTKSLHLHMYLMLLKELPGEEYPLPMEDVLELLKPLSNVCSLYRRDQDVCKTILNHVLHVVKNLGQSNMDSENTRDAQGQFLTVIGAFWHLTKERKYIFSVRMALVNCLKTLLEADPYSKWAILNVMGKDFPVNEVFTQFLADNHHQVRMLAAESINRLFQDTKGDSSRLLKALPLKLQQTAFENAYLKAQEGMREMSHSAENPETLDEIYNRKSVLLTLIAVVLSCSPICEKQALFALCKSVKENGLEPHLVKKVLEKVSETFGYRRLEDFMASHLDYLVLEWLNLQDTEYNLSSFPFILLNYTNIEDFYRSCYKVLIPHLVIRSHFDEVKSIANQIQEDWKSLLTDCFPKILVNILPYFAYEGTRDSGMAQQRETATKVYDMLKSENLLGKQIDHLFISNLPEIVVELLMTLHEPANSSASQSTDLCDFSGDLDPAPNPPHFPSHVIKATFAYISNCHKTKLKSILEILSKSPDSYQKILLAICEQAAETNNVYKKHRILKIYHLFVSLLLKDIKSGLGGAWAFVLRDVIYTLIHYINQRPSCIMDVSLRSFSLCCDLLSQVCQTAVTYCKDALENHLHVIVGTLIPLVYEQVEVQKQVLDLLKYLVIDNKDNENLYITIKLLDPFPDHVVFKDLRITQQKIKYSRGPFSLLEEINHFLSVSVYDALPLTRLEGLKDLRRQLELHKDQMVDIMRASQDNPQDGIMVKLVVNLLQLSKMAINHTGEKEVLEAVGSCLGEVGPIDFSTIAIQHSKDASYTKALKLFEDKELQWTFIMLTYLNNTLVEDCVKVRSAAVTCLKNILATKTGHSFWEIYKMTTDPMLAYLQPFRTSRKKFLEVPRFDKENPFEGLDDINLWIPLSENHDIWIKTLTCAFLDSGGTKCEILQLLKPMCEVKTDFCQTVLPYLIHDILLQDTNESWRNLLSTHVQGFFTSCLRHFSQTSRSTTPANLDSESEHFFRCCLDKKSQRTMLAVVDYMRRQKRPSSGTIFNDAFWLDLNYLEVAKVAQSCAAHFTALLYAEIYADKKSMDDQEKRSLAFEEGSQSTTISSLSEKSKEETGISLQDLLLEIYRSIGEPDSLYGCGGGKMLQPITRLRTYEHEAMWGKALVTYDLETAIPSSTRQAGIIQALQNLGLCHILSVYLKGLDYENKDWCPELEELHYQAAWRNMQWDHCTSVSKEVEGTSYHESLYNALQSLRDREFSTFYESLKYARVKEVEEMCKRSLESVYSLYPTLSRLQAIGELESIGELFSRSVTHRQLSEVYIKWQKHSQLLKDSDFSFQEPIMALRTVILEILMEKEMDNSQRECIKDILTKHLVELSILARTFKNTQLPERAIFQIKQYNSVSCGVSEWQLEEAQVFWAKKEQSLALSILKQMIKKLDASCAANNPSLKLTYTECLRVCGNWLAETCLENPAVIMQTYLEKAVEVAGNYDGESSDELRNGKMKAFLSLARFSDTQYQRIENYMKSSEFENKQALLKRAKEEVGLLREHKIQTNRYTVKVQRELELDELALRALKEDRKRFLCKAVENYINCLLSGEEHDMWVFRLCSLWLENSGVSEVNGMMKRDGMKIPTYKFLPLMYQLAARMGTKMMGGLGFHEVLNNLISRISMDHPHHTLFIILALANANRDEFLTKPEVARRSRITKNVPKQSSQLDEDRTEAANRIICTIRSRRPQMVRSVEALCDAYIILANLDATQWKTQRKGINIPADQPITKLKNLEDVVVPTMEIKVDHTGEYGNLVTIQSFKAEFRLAGGVNLPKIIDCVGSDGKERRQLVKGRDDLRQDAVMQQVFQMCNTLLQRNTETRKRKLTICTYKVVPLSQRSGVLEWCTGTVPIGEFLVNNEDGAHKRYRPNDFSAFQCQKKMMEVQKKSFEEKYEVFMDVCQNFQPVFRYFCMEKFLDPAIWFEKRLAYTRSVATSSIVGYILGLGDRHVQNILINEQSAELVHIDLGVAFEQGKILPTPETVPFRLTRDIVDGMGITGVEGVFRRCCEKTMEVMRNSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQRPEDETELHPTLNADDQECKRNLSDIDQSFNKVAERVLMRLQEKLKGVEEGTVLSVGGQVNLLIQQAIDPKNLSRLFPGWKAWV
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
Atypical protein kinase group
>
Atypical protein kinase PIKK family
Function
Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor (PubMed:9733514, PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15456891, PubMed:15448695, PubMed:15916964, PubMed:17923702). Recognizes the substrate consensus sequence [ST]-Q (PubMed:9733514, PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15456891, PubMed:15448695, PubMed:15916964, PubMed:17923702). Phosphorylates 'Ser-139' of histone variant H2AX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism (By similarity). Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FBXW7, FANCD2, NFKBIA, BRCA1, CTIP, nibrin (NBN), TERF1, UFL1, RAD9, UBQLN4 and DCLRE1C (PubMed:9843217, PubMed:9733515, PubMed:10550055, PubMed:10766245, PubMed:10839545, PubMed:10910365, PubMed:10802669, PubMed:10973490, PubMed:11375976, PubMed:12086603, PubMed:15456891, PubMed:19965871, PubMed:30612738, PubMed:30886146, PubMed:26774286). May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation (PubMed:19965871). Phosphorylates ATF2 which stimulates its function in DNA damage response (PubMed:15916964). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (PubMed:29203878). Phosphorylates TTC5/STRAP at 'Ser-203' in the cytoplasm in response to DNA damage, which promotes TTC5/STRAP nuclear localization (PubMed:15448695). Also involved in pexophagy by mediating phosphorylation of PEX5: translocated to peroxisomes in response to reactive oxygen species (ROS), and catalyzes phosphorylation of PEX5, promoting PEX5 ubiquitination and induction of pexophagy (PubMed:26344566).
    Show/Hide
Uniprot ID
Primary ID:
Q13315

Secondarily ID:
B2RNX5
O15429
Q12758
Q16551
Q93007
Q9NP02
Q9UCX7
    Show/Hide
Ensembl ID
ENSG00000149311
HGNC ID
HGNC:795
Subcellular Location
Nucleus
Cytoplasmic vesicle
Cytoplasm
Cytoskeleton
Microtubule organizing center
Centrosome
Peroxisome matrix
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000068 , A-549
Compound ID Compound Name Compound Formula
CP0127298
US9428503, 1
   Show/Hide
C26H31N5O3
 1
1
IC50 = 0.22 nM
   TI
   LI
   LO
   TS
CP0543231
1-[2-(3-fluoroazetidin-1-yl)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C26H29FN6O3
 1
1
IC50 = 0.32 nM
   TI
   LI
   LO
   TS
CP0570533
1-[2-(dimethylamino)ethyl]-3-[3-fluoro-4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C25H29FN6O3
 1
1
IC50 = 0.65 nM
   TI
   LI
   LO
   TS
CP0579910
1-[2-(dimethylamino)ethyl]-3-[2-fluoro-4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C25H29FN6O3
 1
1
IC50 = 0.71 nM
   TI
   LI
   LO
   TS
CP0579538
1-[2-(azetidin-1-yl)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C26H30N6O3
 1
1
IC50 = 0.92 nM
   TI
   LI
   LO
   TS
CP0579833
1-[2-(dimethylamino)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]-1-methylurea
   Show/Hide
C26H32N6O3
 1
1
IC50 = 1.33 nM
   TI
   LI
   LO
   TS
CP0571170
1-[2-(dimethylamino)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C25H30N6O3
 1
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS
CP0580064
1-[2-(3,3-difluoroazetidin-1-yl)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C26H28F2N6O3
 1
1
IC50 = 3.31 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0127298
US9428503, 1
   Show/Hide
C26H31N5O3
 3
1 IC50 = 0.04 nM
2 IC50 = 0.58 nM
3 IC50 < 1 nM
CP0123998
6-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]cinnoline-3-carboxamide
   Show/Hide
C26H34N6O3
 1
1 IC50 = 0.29 nM
CP0135713
2-[7-[2-(3,3-difluoropyrrolidin-1-yl)ethoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C28H28F2N2O4S
 1
1 IC50 = 0.5 nM
CP0226864
2-morpholin-4-yl-6-[7-[2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C29H30N2O5S
 1
1 IC50 = 0.5 nM
CP0424904
2-[7-[(3-methyloxetan-3-yl)methylamino]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C27H28N2O4S
 1
1 IC50 = 0.5 nM
CP0479254
2-[7-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]ethoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C30H34N2O5S
 1
1 IC50 = 0.5 nM
CP0565205
2-(7-hydroxy-9H-thioxanthen-4-yl)-6-morpholin-4-ylpyran-4-one
   Show/Hide
C22H19NO4S
 1
1 IC50 = 0.5 nM
CP0577962
2-morpholin-4-yl-6-[7-(oxan-4-ylmethoxy)-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C28H29NO5S
 1
1 IC50 = 0.5 nM
CP0180777
7-fluoro-6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1S)-1-(1-methylpyrazol-3-yl)ethyl]amino]quinoline-3-carboxamide
   Show/Hide
C23H23FN6O2
 1
1 IC50 = 0.6 nM
CP0140864
2-morpholin-4-yl-6-[7-[(2R)-1-morpholin-4-ylpropan-2-yl]oxy-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C29H32N2O5S
 1
1 IC50 = 0.6 nM
CP0533952
N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]cyclopropanecarboxamide
   Show/Hide
C26H24N2O4S
 1
1 IC50 = 0.6 nM
CP0558690
2-[7-[(2S)-2-hydroxypropoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C25H25NO5S
 1
1 IC50 = 0.6 nM
CP0558765
N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]acetamide
   Show/Hide
C24H22N2O4S
 1
1 IC50 = 0.6 nM
CP0558766
2-[7-[2-(3-fluoroazetidin-1-yl)ethoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C27H27FN2O4S
 1
1 IC50 = 0.6 nM
CP0189386
6-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-N-methyl-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]cinnoline-3-carboxamide
   Show/Hide
C27H36N6O3
 1
1 IC50 = 0.7 nM
CP0533954
2-[7-[2-(4-methylpiperazin-1-yl)ethoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C29H33N3O4S
 1
1 IC50 = 0.7 nM
CP0558688
2-morpholin-4-yl-6-[7-[(2S)-2-morpholin-4-ylpropoxy]-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C29H32N2O5S
 1
1 IC50 = 0.7 nM
CP0575089
2-[7-[2-(4,4-difluoropiperidin-1-yl)ethoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C29H30F2N2O4S
 1
1 IC50 = 0.7 nM
CP0180814
2-morpholin-4-yl-6-(9H-thioxanthen-4-yl)pyran-4-one
   Show/Hide
C22H19NO3S
 1
1 IC50 = 0.8 nM
CP0226866
2-morpholin-4-yl-6-[7-[(2R)-2-morpholin-4-ylpropoxy]-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C29H32N2O5S
 1
1 IC50 = 1 nM
CP0355633
2-[7-[(2R)-1-methoxypropan-2-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C26H27NO5S
 1
1 IC50 = 1 nM
CP0534724
2-morpholin-4-yl-6-[7-[(2S)-1-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]propan-2-yl]oxy-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C30H32N2O5S
 1
1 IC50 = 1 nM
CP0552098
2-morpholin-4-yl-6-[7-(oxetan-3-yloxy)-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C25H23NO5S
 1
1 IC50 = 1 nM
CP0558312
2-[7-[(2R)-2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]propoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C31H36N2O5S
 1
1 IC50 = 1 nM
CP0558687
2-morpholin-4-yl-6-[7-[(2S)-1-morpholin-4-ylpropan-2-yl]oxy-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C29H32N2O5S
 1
1 IC50 = 1 nM
CP0565206
2-[7-[(2S)-1-(2,8-dioxa-5-azaspiro[3.5]nonan-5-yl)propan-2-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C31H34N2O6S
 1
1 IC50 = 1 nM
CP0543231
1-[2-(3-fluoroazetidin-1-yl)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C26H29FN6O3
 1
1 IC50 < 1 nM
CP0570533
1-[2-(dimethylamino)ethyl]-3-[3-fluoro-4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C25H29FN6O3
 1
1 IC50 < 1 nM
CP0571170
1-[2-(dimethylamino)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C25H30N6O3
 1
1 IC50 < 1 nM
CP0579538
1-[2-(azetidin-1-yl)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C26H30N6O3
 1
1 IC50 < 1 nM
CP0579833
1-[2-(dimethylamino)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]-1-methylurea
   Show/Hide
C26H32N6O3
 1
1 IC50 < 1 nM
CP0579910
1-[2-(dimethylamino)ethyl]-3-[2-fluoro-4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C25H29FN6O3
 1
1 IC50 < 1 nM
CP0580064
1-[2-(3,3-difluoroazetidin-1-yl)ethyl]-3-[4-[1-(2-methoxyethyl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl]phenyl]urea
   Show/Hide
C26H28F2N6O3
 1
1 IC50 < 1 nM
CP0180776
6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]quinoline-3-carboxamide
   Show/Hide
C24H28N4O3
 2
1 IC50 < 1.2 nM
2 IC50 = 46 nM
CP0253472
2-morpholin-4-yl-6-[7-[2-(7-oxa-1-azaspiro[4.4]nonan-1-yl)ethoxy]-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C31H34N2O5S
 1
1 IC50 = 1.4 nM
CP0016003
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
   Show/Hide
C21H17NO3S2
 6
1 IC50 < 2 nM
2 IC50 = 12.9 nM
3 IC50 = 13 nM
4 IC50 = 14 nM
5 IC50 = 250 nM
6 Ki = 2.2 nM
CP0234613
4-[[(1R)-1-(4-chlorophenyl)ethyl]amino]-6-pyridin-3-ylquinoline-3-carboxamide
   Show/Hide
C23H19ClN4O
 1
1 IC50 = 2 nM
CP0511734
2-[7-[(2R)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]propan-2-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C31H36N2O5S
 1
1 IC50 = 2 nM
CP0575090
2-morpholin-4-yl-6-[7-[(2S)-1-(4-oxa-7-azaspiro[2.5]octan-7-yl)propan-2-yl]oxy-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C31H34N2O5S
 1
1 IC50 = 2 nM
CP0578997
2-[7-[(2S)-1-[(2R,6S)-2,6-dimethylmorpholin-4-yl]propan-2-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C31H36N2O5S
 1
1 IC50 = 2 nM
CP0140865
2-[7-[(3R)-1-methylpyrrolidin-3-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C27H28N2O4S
 1
1 IC50 = 3 nM
CP0558768
2-[7-[2-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]ethoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C32H38N2O5S
 1
1 IC50 = 3 nM
CP0350913
2-morpholin-4-yl-6-[7-(oxan-4-yloxy)-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C27H27NO5S
 1
1 IC50 = 3.2 nM
CP0558327
2-[7-[(2S)-2-methoxypropoxy]-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C26H27NO5S
 1
1 IC50 = 4 nM
CP0565207
2-[7-[1-(2,2-difluoroethyl)azetidin-3-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C27H26F2N2O4S
 1
1 IC50 = 4 nM
CP0135733
2-(7-methoxy-9H-thioxanthen-4-yl)-6-morpholin-4-ylpyran-4-one
   Show/Hide
C23H21NO4S
 2
1 IC50 = 5 nM
2 Ki = 0.5 nM
CP0577416
2-[(9S)-7-methoxy-9-(methoxymethyl)-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C25H25NO5S
 1
1 IC50 = 5 nM
CP0253471
2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]acetamide
   Show/Hide
C30H33N3O5S
 3
1 IC50 = 6 nM
2 IC50 = 20 nM
3 IC50 = 60 nM
CP0564735
2-[7-(1-ethylazetidin-3-yl)oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C27H28N2O4S
 1
1 IC50 = 7 nM
CP0180782
6-cyano-4-(2-ethylbutylamino)quinoline-3-carboxamide
   Show/Hide
C17H20N4O
 1
1 IC50 = 8 nM
CP0552034
N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]-2-pyrrolidin-1-ylacetamide
   Show/Hide
C28H29N3O4S
 1
1 IC50 = 10 nM
CP0180813
2-(6,7-dimethoxyquinazolin-4-yl)-5-pyridin-2-yl-1,2,4-triazol-3-amine
   Show/Hide
C17H15N7O2
 4
1 IC50 = 12.9 nM
2 IC50 = 20 nM
3 IC50 = 21 nM
4 IC50 = 370 nM
CP0534723
N-methyl-N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]acetamide
   Show/Hide
C25H24N2O4S
 1
1 IC50 = 16 nM
CP0489036
2-[7-[(3R)-1-(2,2-difluoroethyl)pyrrolidin-3-yl]oxy-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C28H28F2N2O4S
 1
1 IC50 = 20 nM
CP0577960
2-morpholin-4-yl-6-[7-[(2S)-1-(2-oxa-5-azaspiro[3.4]octan-5-yl)propan-2-yl]oxy-9H-thioxanthen-4-yl]pyran-4-one
   Show/Hide
C31H34N2O5S
 1
1 IC50 = 30 nM
CP0180780
4-[[(1R)-1-(4-chlorophenyl)ethyl]amino]-6-cyanoquinoline-3-carboxamide
   Show/Hide
C19H15ClN4O
 1
1 IC50 = 49 nM
CP0534725
2-(7'-methoxyspiro[oxane-4,9'-thioxanthene]-4'-yl)-6-morpholin-4-ylpyran-4-one
   Show/Hide
C27H27NO5S
 1
1 IC50 = 50 nM
CP0558769
2-(7-methoxy-9,9-dimethylthioxanthen-4-yl)-6-morpholin-4-ylpyran-4-one
   Show/Hide
C25H25NO4S
 1
1 IC50 = 480 nM
CP0562196
2-[(9R)-7-methoxy-9-(methoxymethyl)-9H-thioxanthen-4-yl]-6-morpholin-4-ylpyran-4-one
   Show/Hide
C25H25NO5S
 1
1 IC50 = 530 nM
CP0953816
(R)-2-(2-Benzylazepan-1-yl)-6-morpholinopyrimidin-4(3H)-one
   Show/Hide
C21H28N4O2
 1
1 Ki = 0.1 nM
CP0968778
2-((1R,2S,5S)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-6-morpholinopyrimidin-4(3H)-one
   Show/Hide
C20H24N4O2
 1
1 Ki = 0.2 nM
CP0953200
6-((1S,2S,5R)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C21H25N3O2
 1
1 Ki = 0.3 nM
CP0839448
2-((2S,3R)-2-Benzyl-3-methylpyrrolidin-1-yl)-6-morpholinopyrimidin-4(3H)-one
   Show/Hide
C20H26N4O2
 1
1 Ki = 0.4 nM
CP0965262
2-((1S,2S,5R)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-6-morpholinopyrimidin-4(3H)-one
   Show/Hide
C20H24N4O2
 1
1 Ki = 0.6 nM
CP0967580
2-((1S,2S,5R)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-6-((R)-2-methylmorpholino)pyrimidin-4(3H)-one
   Show/Hide
C21H26N4O2
 1
1 Ki = 0.9 nM
CP0569952
2-[(2R)-2-benzylpyrrolidin-1-yl]-4-morpholin-4-yl-1H-pyrimidin-6-one
   Show/Hide
C19H24N4O2
 1
1 Ki = 1 nM
CP0839447
6-((R)-2-Benzylazepan-1-yl)-4-((R)-2-methylmorpholino)pyridin-2(1H)-one
   Show/Hide
C23H31N3O2
 1
1 Ki = 1 nM
CP0946565
(R)-6-(2-Benzylazepan-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C22H29N3O2
 1
1 Ki = 1 nM
CP0967579
2-((R)-2-Benzylazepan-1-yl)-6-((R)-2-methylmorpholino)pyrimidin-4(3H)-one
   Show/Hide
C22H30N4O2
 1
1 Ki = 1 nM
CP0953818
2-((1R,2S,5S)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-6-((R)-2-methylmorpholino)pyrimidin-4(3H)-one
   Show/Hide
C21H26N4O2
 1
1 Ki = 2 nM
CP0953820
6-((1R,2S,5S)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C21H25N3O2
 1
1 Ki = 2 nM
CP0968777
6-((2S,3R)-2-Benzyl-3-fluoropyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C20H24FN3O2
 1
1 Ki = 3 nM
CP0547036
6-(7-methoxy-9H-thioxanthen-4-yl)-4-morpholin-4-yl-1H-pyridin-2-one
   Show/Hide
C23H22N2O3S
 1
1 Ki = 4 nM
CP0953819
6-((1S,2S,5R)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-((R)-2-methylmorpholino)pyridin-2(1H)-one
   Show/Hide
C22H27N3O2
 1
1 Ki = 4 nM
CP0953815
(R)-6-(2-Benzylpyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C20H25N3O2
 1
1 Ki = 6 nM
CP0968776
(S)-6-(2-Benzyl-3,3-difluoropyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C20H23F2N3O2
 1
1 Ki = 6 nM
CP0955420
(R)-6-(2-Benzylpiperidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C21H27N3O2
 1
1 Ki = 8 nM
CP0965944
6-((1R,2S,5S)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-((R)-2-methylmorpholino)pyridin-2(1H)-one
   Show/Hide
C22H27N3O2
 1
1 Ki = 11 nM
CP0965110
6-((2S,3R)-2-Benzyl-3-methoxypyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C21H27N3O3
 1
1 Ki = 23 nM
CP0363798
4-(7-methoxy-9H-thioxanthen-4-yl)-2-morpholin-4-yl-1H-pyrimidin-6-one
   Show/Hide
C22H21N3O3S
 1
1 Ki = 25 nM
CP0839445
Rac-6-(2-Benzylpyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C20H25N3O2
 1
1 Ki = 30 nM
CP0575459
4-[(2R)-2-benzylpyrrolidin-1-yl]-2-morpholin-4-yl-1H-pyrimidin-6-one
   Show/Hide
C19H24N4O2
 1
1 Ki = 87 nM
CP0575458
2-(7-methoxy-9H-thioxanthen-4-yl)-6-morpholin-4-yl-1H-pyridin-4-one
   Show/Hide
C23H22N2O3S
 1
1 Ki = 110 nM
CP0573591
6-(7-methoxy-9H-thioxanthen-4-yl)-4-morpholin-4-yl-1H-pyrimidin-2-one
   Show/Hide
C22H21N3O3S
 1
1 Ki = 160 nM
CP0966210
(S)-6-(2-benzylpyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C20H25N3O2
 1
1 Ki > 900 nM
CP0547037
4-(7-methoxy-9H-thioxanthen-4-yl)-6-morpholin-4-yl-1H-pyridin-2-one
   Show/Hide
C23H22N2O3S
 1
1 Ki > 1000 nM
CP0575457
6-(7-methoxy-9H-thioxanthen-4-yl)-1-methyl-4-morpholin-4-ylpyridin-2-one
   Show/Hide
C24H24N2O3S
 1
1 Ki > 1200 nM
CP0839446
6-(3-Benzylpyrrolidin-1-yl)-4-morpholinopyridin-2(1H)-one
   Show/Hide
C20H25N3O2
 1
1 Ki > 1200 nM
CP0569555
2-(7-methoxy-9H-thioxanthen-4-yl)-4-morpholin-4-yl-1H-pyrimidin-6-one
   Show/Hide
C22H21N3O3S
 1
1 Ki > 1600 nM
CP0573590
4-[2-methoxy-6-(7-methoxy-9H-thioxanthen-4-yl)pyridin-4-yl]morpholine
   Show/Hide
C24H24N2O3S
 1
1 Ki > 1600 nM
Clinical Information about the Protein
Target 1 ( ATM serine/threonine kinase (ATM) )
Target Type Clinical trial Target
Disease 3 Target-related Diseases  3
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
2 Recurrent glioblastoma [ICD-11: 2A00.00]
3 Non-small-cell lung cancer [ICD-11: 2C25.Y]
Clinical Trial Drug(s) 3 Clinical Trial Drugs  3
1 AZD0156 Phase 1
Solid tumour/cancer
2 AZD1390 Phase 1
Recurrent glioblastoma
3 KU-60019 Clinical trial
Non-small-cell lung cancer